Angela J. Yoon, DDS

Board Certifications: 
Oral and Maxillofacial Pathology
Accepting New Patients
Treats Children
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Dentistry, Oral Cancer, Oral Lesions, Oral Pathology, Oral and Maxillofacial Pathology

Academic Appointments

  • John W. Richter Associate Professor of Oral Pathology (in Dental Medicine and in Pathology and Cell Biology) at CUMC

Administrative Titles

  • Director, Oral & Maxillofacial Pathology Division

Dr. Angela J. Yoon is the Chair of Oral and Maxillofacial Pathology Division at Columbia University College of Dental Medicine and has an interdisciplinary appointment in the Department of Pathology & Cell Biology at Columbia University College of Physicians and Surgeons. She holds a hospital appointment at Columbia University Medical Center and is the Director of the Oral Diagnostic Biopsy Service.

Email: ajk55@cumc.columbia.edu

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Korean

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-4552

Location(s)

CUMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
New York, NY 10032
New Patient Appointments:
212-305-4552
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Columbia University School of Dental & Oral Surgery
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Oral and Maxillofacial Pathology

Honors & Awards

The Edward V Zegarelli Teaching Award (2003)

Research

As an academic Oral & Maxillofacial Pathology clinician-scientist, Dr. Yoon is engaged in number of NIH and non-NIH funded clinical studies and trials, looking to improve oral cancer risk assessment and its management. In specific, Dr. Yoon's study focuses on translating laboratory science into new molecular risk assessment strategies, and improving therapies for oral neoplasms.

Research Interests

  • oral precancer, oral cancer, microRNA biomarkers for prognosis, oral cancer chemoprevention

Grants

  • Molecular biomarker and chemoprevention trials for oral cancer (Role: Principal Investigator, K12 Award from Columbia University CTSA, NCRR-K12-RR024157, 2007-2009).
  • Phase IIb randomized, placebo controlled trial of Pioglitazone for oral leukoplakia, an inter-consortium collaborative study (Role: CUMC site Principal Investigator, NCI-N01-CN35159, 2009-2012).
  • MicroRNA marker-based prognosis of oral cancer survival (Role: Principal Investigator, NIDCR-R03-DE022797, 2013-2015).

MICRORNA-BASED PROGNOSTIC MODEL FOR EARLY-STAGE ORAL CANCER PATIENTS (Federal Gov)

Jul 1 2017 - Jun 30 2021

PREDICTIVE VALUE OF MICRORNAS IN THE PROGRESSION OF ORAL LEUKOPLAKIAS (Federal Gov)

Dec 1 2013 - Nov 30 2015

MICRORNA MARKER-BASED PROGNOSIS OF ORAL CANCER SURVIVAL (Federal Gov)

Jul 1 2013 - Jun 30 2015

PHASE IIB RANDOMIZED, PLACEBO CONTROLLED TRAIL OF PIOGLITAZONE FOR ORAL PREMALIGANANT LESIONS (Federal Gov)

Sep 30 2009 - Sep 29 2012

Selected Publications

  • Yoon et al. 'Activated checkpoint kinase 2 expression and risk for oral squamous cell carcinoma' Cancer Epidemiol Biomarkers Prev. 2007:1;2768-2772.
  • Yoon et al. 'Association between Gly1619ARG polymorphism of IGF2R domain 11 (RS629849) and advanced stage of oral cancer. Med Oncol. 2012;29:682-285.
  • Yoon et al. 'Topical application of green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) fro prevention of recurrent oral neoplastic lesions' JOFS 2012:4;43-45.
  • Yoon et al. 'Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma' Am J Transl Res. 2014;6:580-592.